PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: barber

GnRH analogue injections - University Hospital of South ...

TIG 71/19 Updated: November 2019 Review: November 2021 Page 1 of 4 Saint Mary s Hospital Gynaecology Services Information for Patients gnrh analogue injections Why have I been offered these injections ? Gonadotrophin-releasing hormone ( gnrh ) analogue injections are used for the management of numerous gynaecological conditions including: Endometriosis Uterine fibroids Adenomyosis Menorrhagia Pelvic pain Severe premenstrual syndrome The injections are also used to treat prostate cancer in men. Occasionally your consultant gynaecologist may start you on these injections for other medical reasons.

should only last for the first two weeks of treatment. Ongoing treatment will however cause a reduction of circulating hormones resulting in reduced oestrogen levels which prevent ovulation and in turn cause a medically induced menopause. This menopausal state (anovulation) deprives the endometrial deposits from oestrogen aiming

Fullscreen Download

Tags:

  Only, Injection, Analogue, Menopause, Oestrogen, Gnrh analogue injections, Gnrh

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of GnRH analogue injections - University Hospital of South ...

Documents from same domain

OCCUPATIONAL THERAPY ADVICE

mft.nhs.uk

Occupational therapist to complete pre-school and/or home observation to outline potential sensory difficulties. Review sensory assessment accepted. Page 5 of 43 Trafford Children’s Therapy Service Complied by Alannah Mckaskie (OT) - Version 1 (2018)

  Occupational, Sensory

Cervical Cytology ICE system user manual

mft.nhs.uk

Directorate of Laboratory Medicine 3 | Page 2. Patient records 2.1. Searching for a patient Once logged‐in you should see the page below, use NHS number only to perform a

  Laboratory, Directorate, Directorate of laboratory

Cervical Ectopy (Cervical Erosion)

mft.nhs.uk

Bleeding can also occur if a vaginal infection such as thrush or bacterial vaginosis is present as these common conditions irritate the area. Some women have no symptoms at all and are only diagnosed with an ectopy on routine examinations such as smear tests. What if I’m pregnant? Cervical ectopy is very common during pregnancy.

  Bacterial, Vaginosis, Bacterial vaginosis

Manchester Hospitals (MFT) Anaemia Guide Version 4 Aug ...

mft.nhs.uk

- In non-vegans treatment can be stopped once vitamin B12 levels have been corrected and diet has improved – but monitor B12 levels 6 monthly Advise consumption of foods rich in vitamin B12, eg: foods fortified with vitamin B12 - some soy products, and some breakfast cereals and breads, meat, eggs, and dairy products

  Vitamin, Vitamin b12

Title: Obstetric Cholestasis (OC) diagnosis and management ...

mft.nhs.uk

Risk of stillbirth is unclear but reported to be up to 1-2% when bile acids are > 40mmol/L (Glantz et al, 2004). 2.3. Maternal risks: Maternal morbidity associated with severe pruritus leading to insomnia and exhaustion. Iatrogenic risks from increased rate of induction of labour (Geenes et al, 2014; RCOG, 2011).

  Management, Diagnosis, Obstetrics, Diagnosis and management, Stillbirth, Cholestasis, Obstetric cholestasis

Betamethasone 500 microgram soluble tablets used as …

mft.nhs.uk

Betamethasone 500 microgram soluble tablets used as mouthwash What are the aims of this leaflet? This leaflet has been written to help you understand more about Betamethasone soluble tablets and how they are used as a mouthwash.

  Micrograms

Using steroid ointment on the vulva

mft.nhs.uk

skin conditions of the vulva, such as lichen sclerosus or lichen planus. They are safe and highly effective, but often women will have anxiety about using steroids and be fearful of side effects. This often causes them to use less than they should …

  Using, Steroid, Lichen, Ointment, Lichen sclerosus, Sclerosus, Vulva, Using steroid ointment on the vulva

ADULT HAEMATOLOGY GP Pathway Guides

mft.nhs.uk

High Risk MGUS • IgG>15 • IgM and Ig A>10 Low Risk MGUS • IgG <15 • IgM and IgA <10 • SFLC ratio <8 or >0.1 • No Organ Damage Non-urgent referral to Haematology Urgent referral to . Microcytic Anaemia Microcytic Anaemia

  Pathway, Haematology, Mgus, Haematology gp pathway

Faecal Immunochemical Testing (FIT)

mft.nhs.uk

still follow the 2WW urgent referral pathway Use of FIT in primary care could result in avoidance of invasive tests for patients with negative results. Shorter waiting times for colonoscopies for higher risk patients (including those with FIT positive results).

  Referral

HbA1c

mft.nhs.uk

HbA1c ≤ 48 is tight control and suitable for most patients with type 2 diabetes unless at risk of hypoglycaemia HbA1c ≤ 53 is the target for those at risk of hypoglycaemia HbA1c <58 is good control but lower targets may be appropriate depending on the individual

  Control, Tight, Tight control

Related documents

Understanding the risks of breast cancer - Menopause Matters

www.menopausematters.co.uk

An additional four cases in women on combined hormone replacement therapy (HRT) Four fewer cases in women on oestrogen only Hormone Replacement Therapy (HRT) An additional four cases in women on combined hormonal contraceptives (the pill) An additional ˜ve cases in women who drink 2 or more units of alcohol per day

  Therapy, Only, Menopause, Oestrogen, Oestrogen only

Package Leaflet: Information for the User OESTROGEL® PUMP ...

www.medicines.org.uk

Relief of symptoms occurring after menopause During the menopause, the amount of the oestrogen produced by a woman’s body drops. This can cause symptoms such as hot face, neck and chest (“hot flushes”). Oestrogel alleviates these symptoms after menopause. You will only be prescribed Oestrogel if your symptoms seriously hinder your daily life.

  Only, Menopause, Oestrogen

Osteoporosis risk assessment, diagnosis and management

www.racgp.org.au

therapy If T-score remains below –2.5, and/or there are incident vertebral fractures, continue treatment. Reconsider therapy after 5–10 years in individuals with T-score ≥–2.5 and no recent fractures. Treatment should be restarted if there is continued bone loss or a further minimal trauma fracture (Recommendation 17 D). Repeat BMD testing

  Therapy

Related search queries

Menopause, Therapy, Oestrogen only, Oestrogen, Only